FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component

48798 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Existential restriction modifier (core metadata concept)
Members targetComponentId
16q partial trisomy syndrome Duplication of part of long arm of chromosome 16 (disorder)
17-Hydroxycorticosteroid 17-hydroxycorticosteroid (substance)
17-Hydroxycorticosteroid 17-hydroxycorticosteroid (substance)
18-Hydroxycorticosterone dehydrogenase deficiency Corticosterone 18-monooxygenase deficiency
18-Hydroxycorticosterone dehydrogenase deficiency Corticosterone 18-monooxygenase deficiency
2 to 4 seizures a month Seizure
2 to 4 seizures a month Seizure
2,3-Diaminopropionate oxalyltransferase 2,3-diaminopropionate N-oxalyltransferase
2,3-Diaminopropionate oxalyltransferase 2,3-diaminopropionate N-oxalyltransferase
2,4,5-Trichlorophenoxyacetic acid (substance) 2,4,5-trichlorophenoxyacetic acid (substance)
2,4,5-Trichlorophenoxyacetic acid (substance) 2,4,5-trichlorophenoxyacetic acid (substance)
2,5-Diokovalerate dehydrogenase 2,5-dioxovalerate dehydrogenase (substance)
2,5-Diokovalerate dehydrogenase 2,5-dioxovalerate dehydrogenase (substance)
2-Butanone Methyl ethyl ketone (substance)
2-Butanone Methyl ethyl ketone (substance)
2-Nitro-1,1-bis(p-chlorophenyl) butane 1,1-bis(4-chlorophenyl)-2-nitrobutane (substance)
2-Nitro-1,1-bis(p-chlorophenyl) butane 1,1-bis(4-chlorophenyl)-2-nitrobutane (substance)
2-méthylbutyrylglycinurie 2-methylbutyryl-coenzyme A dehydrogenase deficiency disease (disorder)
2-méthylbutyrylglycinurie 2-methylbutyryl-coenzyme A dehydrogenase deficiency disease (disorder)
2.5 year exam. NOS Child 2.5 year examination (procedure)
2.5 year exam. NOS Child 2.5 year examination (procedure)
2.5 year examination NOS Child examination at 2.5 years with explicit context (situation)
2.5 year examination NOS Child examination at 2.5 years with explicit context (situation)
24 hour urine volume NOS 24 hour urine sample volume measurement
24 hour urine volume NOS 24 hour urine sample volume measurement
24 hour urine volume NOS 24 hour urine sample volume measurement
24 hour urine volume NOS 24 hour urine sample volume measurement
3% Acetic acid Acetic acid
3% Acetic acid Acetic acid
3.5 year exam. NOS Child 3.5 year examination (procedure)
3.5 year exam. NOS Child 3.5 year examination (procedure)
3.5 year examination NOS Child examination at 3.5 years with explicit context (situation)
3.5 year examination NOS Child examination at 3.5 years with explicit context (situation)
4-nitroso dimethylamine N-nitrosodimethylamine (substance)
4-nitroso dimethylamine N-nitrosodimethylamine (substance)
4.5 year exam. NOS Child 4.5 year examination
4.5 year exam. NOS Child 4.5 year examination
4.5 year examination NOS Child examination at 4.5 years with explicit context (situation)
4.5 year examination NOS Child examination at 4.5 years with explicit context (situation)
cariotype 46 XX de type hermaphrodisme 46,XX ovotesticular disorder of sex development (disorder)
cariotype 46 XX de type hermaphrodisme 46,XX ovotesticular disorder of sex development (disorder)
5% Acetic acid Acetic acid
5% Acetic acid Acetic acid
6 meters 6 metres
6 meters 6 metres
6-Iodomethylnorcholesterol[131I] 8-30MBq/mL injection Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-Iodomethylnorcholesterol[131I] 8-30MBq/mL injection Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-Iodomethylnorcholesterol[131I] 8-30MBq/mL injection 6-Iodomethylnorcholesterol[131I] 8-30MBq/mL powder for injection solution vial
6-Iodomethylnorcholesterol[131I] 8-30MBq/mL powder for injection solution vial Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-Iodomethylnorcholesterol[131I] 8-30MBq/mL powder for injection solution vial Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-Iodomethylnorcholesterol[131I]37MBq/mL injection Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-Iodomethylnorcholesterol[131I]37MBq/mL injection Norcholestenol iodomethyl (131-I) only product in parenteral dose form
6-ketoprostaglandin F1 6-ketoprostaglandin F1 alpha (substance)
6-ketoprostaglandin F1 6-ketoprostaglandin F1 alpha (substance)
6-minute walk test 6 minute walk test distance
A/N care provider NOS Antenatal care provider (finding)
A/N care provider NOS Antenatal care provider (finding)
A/N care: obstetric risk NOS Antenatal care: obstetric risk (situation)
A/N care: obstetric risk NOS Antenatal care: obstetric risk (situation)
A/N care: precious pregnancy NOS Antenatal care: precious pregnancy (situation)
A/N care: precious pregnancy NOS Antenatal care: precious pregnancy (situation)
A/N care: risk NOS Antenatal risk factors (situation)
A/N care: risk NOS Antenatal risk factors (situation)
A/N care: social risk NOS Antenatal care: social risk (context-dependent category)
A/N care: social risk NOS Antenatal care: social risk (context-dependent category)
A/N risk NOS Antenatal risk factors (situation)
A/N risk NOS Antenatal risk factors (situation)
ABO blood group antibody system ABO blood group system
ABO blood group antibody system ABO blood group system
ABO blood grouping NOS ABO blood grouping
ABO blood grouping NOS ABO blood grouping
ABO blood grouping NOS ABO blood grouping
ABO blood grouping NOS ABO blood grouping
AFP blood test NOS Alpha-fetoprotein blood test
AFP blood test NOS Alpha-fetoprotein blood test
AIDS virus infection, NEC Human immunodeficiency virus infection
AIDS virus infection, NEC Human immunodeficiency virus infection
AIDS with disseminated candidiasis of other and unspecified sites AIDS with disseminated candidiasis
AIDS with or without other conditions Acquired immune deficiency syndrome (disorder)
AIDS with or without other conditions Acquired immune deficiency syndrome (disorder)
AIDS with other and unspecified mycobacteriosis AIDS with mycobacteriosis
AIDS with other specified conditions Acquired immune deficiency syndrome (disorder)
AIDS with other specified conditions Acquired immune deficiency syndrome (disorder)
AIDS with pyrexia AIDS with fever
AIDS with specified diseases of the central nervous system AIDS with central nervous system disorder
AIDS with specified infection, NEC Acquired immune deficiency syndrome (disorder)
AIDS with specified infection, NEC Acquired immune deficiency syndrome (disorder)
AIDS-related complex with or without other conditions Acquired immunodeficiency syndrome (AIDS)-like syndrome (disorder)
Abacavir sulfate 300mg tablet Abacavir (as abacavir sulfate) 300 mg oral tablet
Abacavir sulfate 300mg tablet Abacavir (as abacavir sulfate) 300 mg oral tablet
Abatacept 250mg powder for injection solution 15mL vial Product containing precisely abatacept 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Abatacept 250mg powder for injection solution 15mL vial Product containing precisely abatacept 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Abbe operation for construction of vagina McIndoe operation for construction of vagina
Abbe operation for construction of vagina McIndoe operation for construction of vagina
Abd. distension symptom NOS Abdominal distension symptom
Abd. distension symptom NOS Abdominal distension symptom
Abdomen random pattern flap Random pattern flap
Abdomen random pattern flap Random pattern flap
Abdominal X-ray normal Plain X-ray of abdomen normal
Abdominal X-ray normal Plain X-ray of abdomen normal
Abdominal aortic aneurysm stenting Repair of abdominal aortic aneurysm with insertion of stent (procedure)

Start Page 2 of 488 Next End

Reference Sets

Reference set descriptor

Back to Start